North Little Rock, Arkansas Clinical Trials

A listing of North Little Rock, Arkansas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 144 clinical trials
featured
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

The objective of the RADIANCE II Pivotal study is to demonstrate the effectiveness and safety of the Paradise System in subjects with Stage 2 hypertension on 0-2 medications at the time of consent. Prior to randomization, subjects will be hypertensive in the absence of hypertension medication.

hypertension
angiography
renal angiogram
antihypertensive drugs
hypertensive medication
Central Arkansas Veterans Healthcare System
 (4.6 away) Contact site
  • 877 views
  • 13 Jun, 2021
  • +82 other locations
featured
[Remote] Beyond Listening: A music-based intervention

1.This study is for people with dementia and their family caregiver. 2. The intervention is a 6-week psychoeducational, music-based workshop designed for caregivers of PWD. The caregiver will attend a one-hour, online session for 6 consecutive weeks. Caregivers will implement a daily caregiving routine that incorporates singing, music with movement and …

[Remote] Beyond Listening: A music-based intervention
 (2.9 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +240 other locations
Assessment of the Efficacy Safety and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo, for the treatment of agitation in participants with dementia of the Alzheimer's type.

Clinical Trials Inc.
 (4.6 away) Contact site
  • 379 views
  • 02 Jun, 2021
  • +222 other locations
Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

The purpose of this study is to evaluate the effect of treatment with omecamtiv mecarbil compared with placebo on exercise capacity as determined by cardiopulmonary exercise testing following 20 weeks of treatment with omecamtiv mecarbil or placebo

Arkansas Cardiology Clinic
 (4.6 away) Contact site
  • 62 views
  • 16 Jun, 2021
  • +79 other locations
Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria

The purpose of this study is to determine the efficacy, durability and long-term safety of reloxaliase in patients with enteric hyperoxaluria.

Applied Research Center of Arkansas
 (8.8 away) Contact site
  • 7 views
  • 11 Jun, 2021
  • +73 other locations
Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer

CREST: Combination of sasanlimab and alternative BCG Regimens to Evaluate outcomes with Subcutaneous anti-PD-1 Treatment Phase 3 Design with 3 study Arms (A, B and C). Arms A and B consists of two study drugs, PF-06801591 plus BCG. Arm C consists of one study drug, BCG. The study is designed …

Arkansas Urology
 (8.6 away) Contact site
  • 10 views
  • 09 Jun, 2021
  • +207 other locations
Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)

This is a 2-part randomized, double-blind, placebo-controlled study of APT-1011 in adults and adolescents (12 years) with EoE. Part A will evaluate the efficacy and safety of APT-1011 3 mg administered HS for the induction of response to treatment (histologic and symptomatic) over 12 weeks. Part B will evaluate histological …

esophagogastroduodenoscopy
dysphagia
Adare Pharmaceuticals
 (1.7 away) Contact site
  • 93 views
  • 14 Jun, 2021
  • +141 other locations
Efficacy Safety and Tolerability of Atogepant for the Prevention of Chronic Migraine

This study will evaluate the efficacy, safety and tolerability of atogepant in participants with chronic migraine. This study includes a 12-week treatment period.

migraine
headache
Baptist Health Center for Clinical Research
 (4.6 away) Contact site
  • 576 views
  • 02 Jun, 2021
  • +178 other locations
A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab

This study will evaluate whether adult participants with moderate to severe plaque psoriasis who have been treated with secukinumab or ixekizumab for at least 6 months and are experiencing a suboptimal response may benefit from switching to risankizumab with regard to skin symptoms, quality of life symptoms and psoriasis symptoms. …

secukinumab
ixekizumab
Arkansas Research Trials /ID# 225497
 (8.0 away) Contact site
  • 49 views
  • 16 Jun, 2021
  • +74 other locations
Study to Assess the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.

Clinical Research Site
 (8.3 away) Contact site
  • 0 views
  • 03 Jun, 2021
  • +21 other locations